Medicare can’t cover Alzheimer’s screening. Congress can change that.
The bipartisan ASAP Act clears the roadblock — without mandating coverage.
Email Your Lawmakers
Ask your members of Congress to support the ASAP Act and Medicare coverage of blood-based tests for Alzheimer’s and other dementia.
Call Your Lawmakers
A short call gets noticed. Tell your members of Congress why the Alzheimer’s Screening and Prevention Act matters to you.
Record a Video
Tell your story in your own words. Show lawmakers what earlier answers mean for families facing Alzheimer’s.
Our Impact
Alzheimer’s disease is one of the most critical public health issues in America. That’s why the Alzheimer’s Impact Movement (AIM), the Alzheimer’s Association and our advocates are unrelenting. We fight to support Alzheimer's and dementia research funding and advance bipartisan legislation that will have a positive and meaningful impact on people living with Alzheimer's and their caregivers today and in the future.
With the support of volunteer advocates and bipartisan congressional champions we’re making an impact. Help us persuade policymakers to make Alzheimer’s a national priority.
<10%
Fewer than 10% of people living with mild cognitive impairment ever receive a diagnosis.
9 in 10
Voters say Medicare should cover Alzheimer’s blood tests.
Zero
Under current law, Medicare cannot cover any screening test for diseases that cause dementia.
Latest News
AIM Blog
Recognizing AIM’s October Advocate of the Month: Adam Nielsen
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top of mind in Congres...
Alzheimer’s Policy in the States
Across the nation AIM advocates are working to advance public policies to improve the lives of individuals and families impacted by Alzheimer’s and all other dementia. Learn about Alzheimer’s policies and advocacy in your state.